In addition to the contingent tender offer in place for calendar year 2026 (as described in the January 16, 2025 press release), the Board of Trustees ("Board†) approved a contingent tender offer for calendar year 2027. Under the terms of the updated Program, the Board approved extending the Program through the year ending December 31, 2027. Under the Program's extension, the Fund will conduct a tender offer for 10% of the Fund's outstanding shares of common stock at a price equal to 98% of NAV per share ...